litlas
Log inCreate account

Desmond Schatz

Active 1990–2025

140
Papers
30,097
Citations
85
h-index
134
i10-index

Citations

Citations per year for Desmond Schatz1992: 8 citations1993: 7 citations1994: 4 citations1995: 8 citations1996: 8 citations1997: 6 citations1998: 26 citations1999: 49 citations2000: 40 citations2001: 63 citations2002: 67 citations2003: 61 citations2004: 58 citations2005: 44 citations2006: 42 citations2007: 40 citations2008: 45 citations2009: 51 citations2010: 86 citations2011: 108 citations2012: 164 citations2013: 171 citations2014: 175 citations2015: 230 citations2016: 233 citations2017: 287 citations2018: 327 citations2019: 953 citations2020: 1,293 citations2021: 1,517 citations2022: 1,207 citations2023: 1,109 citations2024: 1,642 citations2025: 878 citations2026: 29 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,201 citing papers, 27.1% of this breakdownUnited Kingdom: 917 citing papers, 7.7% of this breakdownChina: 797 citing papers, 6.7% of this breakdownItaly: 600 citing papers, 5.1% of this breakdownGermany: 588 citing papers, 5% of this breakdownCanada: 451 citing papers, 3.8% of this breakdownAustralia: 427 citing papers, 3.6% of this breakdownSweden: 376 citing papers, 3.2% of this breakdownFrance: 297 citing papers, 2.5% of this breakdownDenmark: 262 citing papers, 2.2% of this breakdownSpain: 253 citing papers, 2.1% of this breakdownFinland: 251 citing papers, 2.1% of this breakdown
0%27.1%Other 28.9%

Institutions

Fields

  • Medicine50%
  • Biochemistry, Genetics and Molecular Biology37.3%
  • Immunology and Microbiology6%
  • Health Professions1.3%
  • Neuroscience0.9%
  • Agricultural and Biological Sciences0.8%
  • Other3.7%

Topics

  • Diabetes Management and Research14.2%
  • Diabetes and associated disorders13.8%
  • Pancreatic function and diabetes11.2%
  • Gut microbiota and health4.2%
  • Diabetes Treatment and Management2.7%
  • Immune Cell Function and Interaction2.6%
  • Other51.3%

Coauthors

All papers

Open in search
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Authors: Tadej Battelino, Thomas Danne, Richard M. Bergenstal, Stephanie A. Amiel, Roy W. Beck, Torben Biester, Emanuele Bosi, Bruce A. Buckingham, William T. Cefalu, Kelly L. Close, Claudio Cobelli, Eyal Dassau, J. Hans DeVries, Kim C. Donaghue, Klemen Dovč, Francis J. Doyle, Satish K. Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron J. Kowalski, Lori M. Laffel, Brian J. Levine, Alexander Yur'evich Mayorov, Chantal Mathieu, Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 cited by 3,797

  2. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

    Authors: Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum - New England Journal of Medicine 2019 cited by 1,112

  3. Type 1 diabetes mellitus

    Authors: Anastasia Katsarou, Soffia Guðbjörnsdóttir, Araz Rawshani, Dana Dabelea, Ezio Bonifacio, Barbara J. Anderson, Laura M. Jacobsen, Desmond Schatz, Åke Lernmark - Nature Reviews Disease Primers 2017 cited by 1,438

  4. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

    Authors: Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler - Diabetes Care 2015 cited by 1,148

  5. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

    Authors: Moshe Phillip, Revital Nimri, Richard M. Bergenstal, Katharine Barnard‐Kelly, Thomas Danne, Roman Hovorka, Boris Kovatchev, Laurel H. Messer, Christopher G. Parkin, Louise Ambler-Osborn, Stephanie A. Amiel, Lia Bally, Roy W. Beck, Sarah Biester, Torben Biester, Julia E. Blanchette, Emanuele Bosi, Charlotte K. Boughton, Marc D. Breton, Sue A. Brown, Bruce A. Buckingham, Albert Cai, Anders L. Carlson, Jessica R. Castle, Pratik Choudhary, Kelly L. Close, Claudio Cobelli, Amy Criego, Elizabeth A. Davis, Carine de Beaufort, Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovč, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana Gershenoff, Linda Gonder‐Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron J. Kowalski, Lori M. Laffel, Julia Lawton, Rayhan Lal, Lalantha Leelarathna, David M. Maahs, Helen Murphy, Kirsten Nørgaard, David N. O’Neal, Sean M. Oser, Tamara K. Oser, Éric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino - Endocrine Reviews 2022 cited by 402

  6. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

    Authors: Emily K. Sims, Brian N. Bundy, Kenneth Stier, Elisavet Serti, Noha Lim, S. Alice Long, Susan Geyer, Antoinette Moran, Carla J. Greenbaum, Carmella Evans‐Molina, Kevan C. Herold, Type 1 Diabetes TrialNet Study Group, Linda A. DiMeglio, Stephen E. Gitelman, Peter A. Gottlieb, Jennifer B. Marks, Wayne D. Moore, Henry Rodriguez, William E. Russell, Desmond Schatz, Eva Tsalikian, Diane K. Wherrett, Anette‐Gabriele Ziegler - Science Translational Medicine 2021 cited by 359

  7. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Authors: Mark D. Pescovitz, Carla J. Greenbaum, Heidi Krause‐Steinrauf, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Paula McGee, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, John M. Lachin, Jay S. Skyler - New England Journal of Medicine 2009 cited by 1,073

  8. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

    Authors: Richard M. Bergenstal, Revital Nimri, Roy W. Beck, Amy Criego, Lori M. Laffel, Desmond Schatz, Tadej Battelino, Thomas Danne, Stuart A. Weinzimer, Judy Sibayan, Mary L. Johnson, Ryan Bailey, Peter Calhoun, Anders L. Carlson, Elvira Isganaitis, Rachel Bello, Anastasia Albanese-O’Neill, Klemen Dovč, Torben Biester, Kate Weyman, Korey K. Hood, Moshe Phillip - The Lancet 2021 cited by 328

  9. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Authors: Jay S. Skyler, George L. Bakris, Ezio Bonifacio, Tamara Darsow, Robert H. Eckel, Leif Groop, Per‐Henrik Groop, Yehuda Handelsman, Richard A. Insel, Chantal Mathieu, Allison T. McElvaine, Jerry P. Palmer, Alberto Pugliese, Desmond Schatz, Jay M. Sosenko, John Wilding, Robert E. Ratner - Diabetes 2016 cited by 824

  10. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

    Authors: Revital Nimri, Tadej Battelino, Lori M. Laffel, Robert H. Slover, Desmond Schatz, Stuart A. Weinzimer, Klemen Dovč, Thomas Danne, Moshe Phillip, Moshe Phillip, Revital Nimri, Shlomit Shalitin, Rachel Bello, Michal Nevo-Shenker, Naama Fisch Shvalb, Galit Shiovitch-Mantzuri, Orit Choresh, Irit Drutz, Yehiel Nava, Alona Hemo, Orna Hermon, Rachel Nave, Tadej Battelino, Klemen Dovč, Nataša Bratina, Darja Smigoe-Schweiger, Brigita Mali, Ana Gianini, Urška Sever, Barbara Murn Berkopec, Lori M. Laffel, Michelle L. Katz, Elvira Isganaitis, Sanjeev N. Mehta, Heidi Quinn, Nisha Naik, Zijing Guo, Lisa K. Volkening, Robert H. Slover, Gregory P. Forlenza, R. Paul Wadwa, G. Todd Alonso, Laurel H. Messer, Lindsey Towers, Katie Thivener, Cari Berget, Samantha Lange, Emily Jost, Maria Rossick-Solis, Desmond Schatz, Michael J. Haller, Paul Hiers, Laura M. Jacobsen, Madison B. Smith, Anastasia O’Neill, Jennifer Hosford, Alexis Perry, Stuart A. Weinzimer, Eda Cengiz, Jennifer L. Sherr, Kathryn Gibbons, Lori Carria, Melinda Zgorski, Thomas Danne, Torben Biester, Olga Kordonouri, Thekla von dem Berge, Sarah Biester, K Remus - Nature Medicine 2020 cited by 237

  11. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

    Authors: Manuela Battaglia, Simi Ahmed, Mark S. Anderson, Mark A. Atkinson, Dorothy Becker, Polly J. Bingley, Emanuele Bosi, Todd M. Brusko, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Carla J. Greenbaum, Peter A. Gottlieb, Kevan C. Herold, Martin J. Hessner, Mikael Knip, Laura M. Jacobsen, Jeffrey P. Krischer, S. Alice Long, Markus Lundgren, Eoin McKinney, Noel G. Morgan, Richard A. Oram, Tomi Pastinen, Michael C. Peters, Alessandra Petrelli, Xiaoning Qian, María J. Redondo, Bart O. Roep, Desmond Schatz, David Skibinski, Mark Peakman - Diabetes Care 2019 cited by 344

  12. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

    Authors: Tihamer Orban, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Philip Raskin, Henry Rodriguez, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler - The Lancet 2011 cited by 601

  13. Identification of tissue-specific cell death using methylation patterns of circulating DNA

    Authors: Roni Lehmann‐Werman, Daniel Neiman, Hai Zemmour, Joshua Moss, Judith Magenheim, Adi Vaknin‐Dembinsky, Sten Rubertsson, Bengt Nellgård, Kaj Blennow, Henrik Zetterberg, Kirsty L. Spalding, Michael J. Haller, Clive Wasserfall, Desmond Schatz, Carla J. Greenbaum, Craig Dorrell, Markus Grompe, Aviad Zick, Ayala Hubert, Myriam Maoz, Volker Fendrich, Detlef K. Bartsch, Talia Golan, Shmuel A. Ben Sasson, Gideon Zamir, Aharon Razin, Howard Cedar, A. M. James Shapiro, Benjamin Gläser, Ruth Shemer, Yuval Dor - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 621

  14. Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes

    Authors: Christopher T. Brown, Austin G. Davis‐Richardson, Adriana Giongo, K.A. Gano, David B. Crabb, Nabanita Mukherjee, George Casella, Jennifer C. Drew, Jorma Ilonen, Mikael Knip, Heikki Hyöty, Riitta Veijola, Tuula Simell, Olli Simell, Josef Neu, Clive Wasserfall, Desmond Schatz, Mark A. Atkinson, Eric W. Triplett - PLoS ONE 2011 cited by 780

  15. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes

    Authors: the TEDDY Study Group, Kendra Vehik, Kristian Lynch, Matthew C. Wong, Xiangjun Tian, Matthew C. Ross, Richard A. Gibbs, Nadim J. Ajami, Joseph F. Petrosino, Marian Rewers, Jorma Toppari, Anette G. Ziegler, Jin‐Xiong She, Åke Lernmark, Beena Akolkar, William Hagopian, Desmond Schatz, Jeffrey P. Krischer, Heikki Hyöty, Richard E. Lloyd - Nature Medicine 2019 cited by 239

  16. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

    Authors: Thomas Danne, Satish K. Garg, Anne L. Peters, John B. Buse, Chantal Mathieu, Jeremy Pettus, Charles M. Alexander, Tadej Battelino, Francisco Javier Ampudia‐Blasco, Bruce W. Bode, Bertrand Cariou, Kelly L. Close, Paresh Dandona, Sanjoy Dutta, Ele Ferrannini, Spiros Fourlanos, George Grunberger, Simon Heller, Robert R. Henry, Martin J. Kurian, Jake A. Kushner, Tal Oron, Christopher G. Parkin, Thomas R. Pieber, Helena W. Rodbard, Desmond Schatz, Jay S. Skyler, William V. Tamborlane, Koutaro Yokote, Moshe Phillip - Diabetes Care 2019 cited by 356

  17. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association

    Authors: Jane L. Chiang, David M. Maahs, Katharine C. Garvey, Korey K. Hood, Lori M. Laffel, Stuart A. Weinzimer, Joseph I. Wolfsdorf, Desmond Schatz - Diabetes Care 2018 cited by 510

  18. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study

    Authors: the TEDDY Study Group, Jeffrey P. Krischer, Kristian Lynch, Desmond Schatz, Jorma Ilonen, Åke Lernmark, William Hagopian, Marian Rewers, Jin‐Xiong She, Olli Simell, Jorma Toppari, Anette‐G. Ziegler, Beena Akolkar, Ezio Bonifacio - Diabetologia 2015 cited by 436

  19. A combined risk score enhances prediction of type 1 diabetes among susceptible children

    Authors: Lauric A. Ferrat, Kendra Vehik, Seth A. Sharp, Åke Lernmark, Marian Rewers, Jin‐Xiong She, Anette‐G. Ziegler, Jorma Toppari, Beena Akolkar, Jeffrey P. Krischer, Michael N. Weedon, Richard A. Oram, William Hagopian, TEDDY Study Group, Aaron Barbour, Kimberly Bautista, Judith Baxter, Daniel Felipe-Morales, Kimberly A. Driscoll, Brigitte I. Frohnert, Marisa Stahl, Patricia Gesualdo, Michelle Hoffman, Rachel Karban, Edwin Liu, Jill M. Norris, Stesha Peacock, Hanan Shorrosh, Andrea K. Steck, Megan Stern, Erica Villegas, Kathleen Waugh, Olli Simell, Annika Adamsson, Suvi Ahonen, Iris Erlund, Leena Hakola, Anne Hekkala, Henna Holappa, Heikki Hyöty, Anni Ikonen, Jorma Ilonen, Sinikka Jäminki, Sanna Jokipuu, Leena Eklund Karlsson, Jukka Kero, Miia Kähönen, Mikael Knip, Minna-Liisa Koivikko, Merja Koskinen, Mirva Koreasalo, Kalle Kurppa, Jarita Kytölä, Tiina Latva-aho, Katri Lindfors, Maria Lönnrot, Elina Mäntymäki, Markus Mattila, Maija E. Miettinen, Katja Multasuo, Teija Mykkänen, Tiina Niininen, Sari Niinistö, Mia Nyblom, Sami Oikarinen, Paula Ollikainen, Zhian Othmani, Sirpa Pohjola, Petra Rajala, Jenna Rautanen, Anne Riikonen, Eija Riski, Miia Pekkola, Minna Romo, Satu Ruohonen, Satu Simell, Maija Sjöberg, Aino Stenius, Päivi Tossavainen, Mari Vähä-Mäkilä, Sini Vainionpää, Eeva Varjonen, Riitta Veijola, Irene Viinikangas, Suvi Μ. Virtanen, Desmond Schatz, Diane Hopkins, Leigh Steed, Jennifer Bryant, Katherine Silvis, Michael Haller, Melissa Gardiner, Richard McIndoe, Ashok Sharma, Stephen W. Anderson, Laura M. Jacobsen, John Marks, P.D. Towe, Ezio Bonifacio, Cigdem Gezginci and 300 more - Nature Medicine 2020 cited by 143

  20. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    Authors: Michael J. Haller, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, M. Battaglia, Dorothy Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco and 212 more - Diabetes Care 2018 cited by 180

  21. Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes

    Authors: Martha Campbell‐Thompson, Ann Fu, John S. Kaddis, Clive Wasserfall, Desmond Schatz, Alberto Pugliese, Mark A. Atkinson - Diabetes 2015 cited by 361

  22. B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

    Authors: Mark D. Pescovitz, Carla J. Greenbaum, Brian N. Bundy, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, the Type 1 Diabetes TrialNet Anti-CD20 Study Group - Diabetes Care 2013 cited by 282

  23. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

    Authors: Antoinette Moran, Brian N. Bundy, Dorothy Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Philip Raskin, Srinath Sanda, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler, Linda Pickersgill, Eelco J.P. de Koning, Anette‐G. Ziegler, Bernhard O. Boehm, Klaus Badenhoop, Nanette C. Schloot, J. F. Bak, Paolo Pozzilli, Dı́dac Mauricio, Marc Y. Donath, Luís Castaño, Ana M. Wägner, H. H. Lervang, Hans Perrild, Thomas Mandrup‐Poulsen - The Lancet 2013 cited by 354

  24. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

    Authors: María J. Redondo, Susan Geyer, Andrea K. Steck, Seth A. Sharp, John M. Wentworth, Michael N. Weedon, Peter A. Antinozzi, Jay M. Sosenko, Mark A. Atkinson, Alberto Pugliese, Richard A. Oram, Type 1 Diabetes TrialNet Study Group, Peter A. Antinozzi, Mark A. Atkinson, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Peter G. Colman, Peter A. Gottlieb, Kevan C. Herold, Richard A. Insel, Tom Kay, Mikael Knip, Jennifer B. Marks, Antoinette Moran, James L. Palmer, Mark Peakman, Louis H. Philipson, Alberto Pugliese, P. Raskin, Henry Rodriguez, Bart O. Roep, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Christophe Benoıst, J.J. Blum, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, Bernhard J. Hering, Francine Kaufman, Ellen Leschek, J. Mahon, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, Maria Grazia Roncarolo, Olli Simell, Robert Sherwin, Mark Siegelman, Andrea K. Steck, James W. Thomas, Massimo Trucco, J. Richard Wagner, Carla J. Greenbaum, Katarzyna Bourcier, Richard A. Insel, Jeffrey P. Krischer, Ellen Leschek, Lisa Rafkin, Lisa M. Spain, Catherine C. Cowie, Mary A. Foulkes, Heidi Krause‐Steinrauf, John M. Lachin, Saúl Malozowski, John Peyman, J P Ridge, Peter J. Savage, Jay S. Skyler, Stephanie J. Zafonte, Norma S. Kenyon, Irene Santiago, Jay M. Sosenko, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Darlene Amado, Ilma Asif, Matthew Boonstra, Brian N. Bundy, Cristina Burroughs, David Cuthbertson, Mary Deemer, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson and 1,520 more - Diabetes Care 2018 cited by 169